Medicare Diabetic Shoe Program: Eligibility and Billing

The Medicare Therapeutic Shoe Program provides coverage for therapeutic shoes and inserts for patients with diabetes, yet fewer than 10% of eligible Medicare beneficiaries actually receive this benefit each year. For wound care practices managing diabetic foot ulcers, the shoe program is not optional — it is a core component of recurrence prevention. A healed diabetic foot ulcer that recurs because the patient returned to off-the-shelf footwear represents a failure in the care plan, not just a missed billing opportunity.

Understanding the eligibility requirements, certification process, fitting documentation, and HCPCS codes for the diabetic shoe program allows wound care practices to integrate this preventive intervention into their standard DFU management protocol.

Eligibility Requirements for the Medicare Diabetic Shoe Program

Medicare Part B covers therapeutic shoes and inserts under the Therapeutic Shoe Bill (Section 4072 of the Omnibus Budget Reconciliation Act of 1990). The eligibility criteria are specific and must all be met before footwear is ordered.

Qualifying Conditions

The patient must have diabetes mellitus (Type 1 or Type 2) and at least one of the following conditions documented in the medical record:

Previous partial or complete foot amputation — any level, including toe amputation
History of previous foot ulceration — documented prior DFU on either foot
History of pre-ulcerative callus — callus formation indicating abnormal pressure distribution
Peripheral neuropathy with evidence of callus formation — loss of protective sensation combined with pressure-related skin changes
Foot deformity — bunions, hammertoes, Charcot foot, or other structural abnormalities that create abnormal pressure points
Poor circulation — documented peripheral vascular disease affecting the lower extremities

Most wound care patients with a history of diabetic foot ulcers qualify under at least two of these criteria. The qualifying condition must be documented by the certifying physician in the medical record — a verbal acknowledgment or checkbox form does not meet the standard.

Annual Certification Requirement

The diabetic shoe program requires annual certification by the treating physician (MD or DO) who manages the patient's diabetes. This is a critical distinction: the physician who certifies the need for therapeutic shoes must be the provider managing the patient's systemic diabetes care, not necessarily the wound care provider.

The certification statement must include:

Confirmation that the patient has diabetes
The specific qualifying condition(s) from the list above
A statement that the patient needs therapeutic shoes as part of a comprehensive diabetes care plan
The date of the face-to-face encounter at which the evaluation was performed

The certification must be completed within six months before the shoe is dispensed. A certification older than six months at the time of fitting requires recertification.

Fitting Documentation and Dispensing Requirements

The fitting and dispensing process has specific requirements that differ from standard DME orders. Missing any of these steps creates a gap in the documentation chain that results in denial.

Who Can Fit and Dispense

Therapeutic shoes must be fitted and furnished by a podiatrist, pedorthist, prosthetist, or orthotist. The fitting provider does not have to be the certifying physician, but the fitting documentation must be completed by a qualified professional with the appropriate credentials.

Required Fitting Documentation

The fitting encounter must document:

Foot measurements: Both feet must be measured independently. Length, width, and depth measurements are the minimum. For custom-molded shoes, a cast or impression of the foot is also required.

Shoe selection rationale: The documentation must explain why the specific shoe type (depth shoe vs. custom-molded shoe) was selected based on the patient's foot characteristics and qualifying condition.

Insert specification: If inserts are ordered (most therapeutic shoe orders include them), the type of insert and its accommodation features must be documented. Custom-molded inserts require a separate impression or mold.

Patient education: The record should reflect that the patient received education on proper use of the therapeutic footwear, including break-in schedule, daily foot inspection requirements, and when to contact the provider about fit issues.

Dispensing Timeline

The shoes and inserts must be dispensed within the same calendar year as the physician certification. A certification completed in November with shoes not dispensed until February of the following year is non-compliant. The dispensing date — not the order date — must fall within the calendar year of certification.

HCPCS Codes for the Diabetic Shoe Program

The diabetic shoe program uses a specific set of HCPCS codes. Selecting the wrong code or billing shoes and inserts outside the allowed quantities triggers automatic denial.

Shoe Codes

A5500 — Diabetic shoe, depth shoe: The standard therapeutic shoe for most diabetic patients. Depth shoes have additional depth in the toe box (typically 1/4 to 1/2 inch deeper than standard shoes) to accommodate custom inserts and foot deformities. Medicare covers one pair per calendar year.

A5501 — Diabetic shoe, custom-molded: Custom-molded shoes are fabricated from a cast or model of the patient's foot. These are covered only when the patient cannot be fitted with a depth shoe due to foot deformity. The documentation must explicitly state why a depth shoe is insufficient. Medicare covers one pair per calendar year.

Insert Codes

A5512 — Multiple-density insert, direct-formed, molded to foot: The most commonly billed insert code for the diabetic shoe program. Medicare covers three pairs of inserts per calendar year.

A5513 — Multiple-density insert, custom-molded: Custom-molded inserts fabricated from a positive model of the patient's foot. These require a mold or impression and are covered when direct-formed inserts cannot adequately accommodate the foot. Medicare covers three pairs per calendar year.

Modification Codes

A5503 through A5507 — Shoe modifications: These codes cover specific modifications to the therapeutic shoe, including rocker bottoms (A5503), metatarsal bars (A5504), wedge modifications (A5505), and other structural changes. Modifications are billed in addition to the base shoe code when medically necessary.

Coverage Quantities

Per calendar year, Medicare covers:

One pair of depth shoes (A5500) and three pairs of inserts, OR
One pair of custom-molded shoes (A5501) and two pairs of inserts (the shoe itself serves as one insert equivalent)

Billing beyond these quantities in a single calendar year results in denial for the excess items.

Integrating the Shoe Program Into DFU Care Plans

For wound care practices, the diabetic shoe program should not be an afterthought triggered by ulcer recurrence. It should be a standard component of every DFU care plan initiated when the wound is actively being managed, with the shoe order timed to coincide with or closely follow wound closure.

When to Initiate the Process

The certification process should begin while the DFU is still healing. Because the certifying physician is the diabetes managing provider — not always the wound care clinician — coordination is required. The wound care provider should communicate the qualifying condition documentation to the managing physician and request certification.

For practices managing patients with active DFUs who also use offloading strategies, the transition from therapeutic offloading devices (total contact casts, removable cast walkers) to therapeutic shoes represents a planned step in the care continuum, not a separate service.

Recurrence Prevention Documentation

Documenting the therapeutic shoe as a recurrence prevention measure strengthens the medical necessity case and ties the shoe order directly to the wound care treatment plan. The note should reference:

The healed or healing DFU site
The qualifying condition (prior ulceration, neuropathy with callus, deformity)
The rationale for therapeutic footwear as recurrence prevention
The transition plan from offloading device to therapeutic shoe

This documentation connects the shoe program to the clinical outcome rather than presenting it as an isolated DME order.

Key Takeaways

The Medicare Therapeutic Shoe Program requires annual certification by the physician managing the patient's diabetes — not the wound care provider — and the certification must be completed within six months before the shoe is dispensed.
Patients must have documented diabetes plus at least one qualifying foot condition (prior amputation, prior ulcer, pre-ulcerative callus, neuropathy with callus, foot deformity, or poor circulation) to be eligible.
Medicare covers one pair of depth shoes (A5500) or custom-molded shoes (A5501) plus up to three pairs of inserts (A5512 or A5513) per calendar year, with shoes and inserts dispensed within the same calendar year as certification.
The shoe program should be integrated into every DFU care plan as a recurrence prevention measure, with the certification process initiated while the wound is still healing rather than after closure.
Custom-molded shoes (A5501) require explicit documentation that a depth shoe cannot accommodate the patient's foot deformity — without this justification, the claim will be denied.